Study Evaluation of Recombinant Hirudin in Prophylaxis of Post-Operative Deep Vein Thrombosis
Clinical trial NCT05847205 · UNKNOWN
Trial details
- NCT number
- NCT05847205
- Sponsor
- MinaPharm Pharmaceuticals
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-24
- Primary completion
- 2023-12-31
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.